Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 93996 · Class II · ImpactLife
Key facts
| Event ID | 93996 |
|---|---|
| Recall numbers | B-0149-2024, B-0150-2024 |
| Recalling firm | ImpactLife |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced, Apheresis Platelets, Leukocytes Reduced, Irradiated |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Apheresis Platelet products, for which quality control testing for platelet count and pH were not performed, were distributed. |
| Initiation date | Nov 22, 2023 |
| Report date | Mar 6, 2024 |
| Termination date | Feb 27, 2024 |
| City | Davenport |
| State | IA |
| Country | United States |
| FEI number | 1970356 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: